Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder

NCT02478788 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

153

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: mixed amphetamine salts-extended release (MAS-XR)
DRUG: Placebo

Sponsor

University of Cincinnati

Collaborators

[object Object]